Efficacy and safety of Angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and hyponatremia

Louise Balling; Lars Kober; Morten Schou; Christian Torp-Pedersen; Finn Gustafsson

doi:10.1016/j.cardfail.2013.09.004

Efficacy and safety of Angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and hyponatremia

Louise Balling, Lars Kober, Morten Schou, Christian Torp-Pedersen, Finn Gustafsson

6 Citations (Scopus)

Abstract

The presence of hyponatremia has been perceived to increase the risk of adverse events on initiation of treatment with angiotensin-converting enzyme inhibition in heart failure patients. The aim of this study was to investigate if baseline hyponatremia (plasma Na(+)

Original language	English
Journal	Journal of Cardiac Failure
Volume	19
Issue number	11
Pages (from-to)	725-30
Number of pages	6
ISSN	1071-9164
DOIs	https://doi.org/10.1016/j.cardfail.2013.09.004
Publication status	Published - Nov 2013

Access to Document

10.1016/j.cardfail.2013.09.004

Cite this

@article{81a291452a454cdd9d784d56a632e6d5,

title = "Efficacy and safety of Angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and hyponatremia",

abstract = "The presence of hyponatremia has been perceived to increase the risk of adverse events on initiation of treatment with angiotensin-converting enzyme inhibition in heart failure patients. The aim of this study was to investigate if baseline hyponatremia (plasma Na(+) ",

author = "Louise Balling and Lars Kober and Morten Schou and Christian Torp-Pedersen and Finn Gustafsson",

year = "2013",

month = nov,

doi = "10.1016/j.cardfail.2013.09.004",

language = "English",

volume = "19",

pages = "725--30",

journal = "Journal of Cardiac Failure",

issn = "1071-9164",

publisher = "Churchill Livingstone",

number = "11",

}

TY - JOUR

T1 - Efficacy and safety of Angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and hyponatremia

AU - Balling, Louise

AU - Kober, Lars

AU - Schou, Morten

AU - Torp-Pedersen, Christian

AU - Gustafsson, Finn

PY - 2013/11

Y1 - 2013/11

N2 - The presence of hyponatremia has been perceived to increase the risk of adverse events on initiation of treatment with angiotensin-converting enzyme inhibition in heart failure patients. The aim of this study was to investigate if baseline hyponatremia (plasma Na(+)

AB - The presence of hyponatremia has been perceived to increase the risk of adverse events on initiation of treatment with angiotensin-converting enzyme inhibition in heart failure patients. The aim of this study was to investigate if baseline hyponatremia (plasma Na(+)

U2 - 10.1016/j.cardfail.2013.09.004

DO - 10.1016/j.cardfail.2013.09.004

M3 - Journal article

C2 - 24263115

SN - 1071-9164

VL - 19

SP - 725

EP - 730

JO - Journal of Cardiac Failure

JF - Journal of Cardiac Failure

IS - 11

ER -

Efficacy and safety of Angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and hyponatremia

Abstract

Access to Document

Fingerprint

Cite this